About this episode
The CEO of New Zealand's biggest independent medical research organisation, the Malaghan Institute, says the ongoing challenge of funding the organisation keeps her up at night. Professor Kjesten Wiig oversees research into groundbreaking cancer treatments and RNA technology, but says it's juggling the institutes' sources of income that remains a constant concern. In 2015, for example, 61 percent of the institutes' income came from government grants, but last year that had fallen to just 26 percent, even as Malaghan brings the game-changing CAR T-cell cancer therapy ever closer to New Zealand patients.
Comments
Rate this episode
Episode Details
- Show Type
- full
- Audio Format
- audio/mpeg

